source Post navigation Optimal Cardioprotective BMI for Adults with Type 2 Diabetes Could Vary by Age, New Study Suggests – Patient Care Online Weight loss drug semaglutide benefits obese patients presenting with HFpEF, type 2 diabetes – Cardiovascular Business